ARAdriana M. Reedy

Adriana M. Reedy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adriana M. Reedy has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of enhanced peer PrEP referral with HIV self-testing delivery among young Kenyan women: A randomized controlled trial of peer networks

    by Katrina F. Ortblad, Njeri Wairimu, Carlos Culquichicon, Irene Njeru, Rachel C. Malen, Adriana M. Reedy, Obinna Ekwunife, Maureen McGowan, Margaret Mwangi, Agata Muthoni, et al.

    Background: Adolescent girls and young women (AGYW) in Africa experience high HIV acquisition risk and low engagement in prevention services. Knowledge of HIV–negative status paired with peer support might motivate AGYW—who are highly socially connected—to initiate HIV prevention services, including pre-exposure prophylaxis (PrEP). Methods and findings: We conducted a randomized controlled trial (ClinicalTrials.gov: NCT04982250) of AGYW peer networks in Central Kenya. Index peers aged 16–24 years who had used oral PrEP in the past 12 months were randomized 1:1 to: (1) enhanced peer referral: group training on PrEP referral strategies and delivery of HIV self-testing (HIVST) kits ( n = 8 kits, 2 kits/peer); or (2) standard peer referral: informal PrEP referral strategies. Index peers were encouraged to refer four peers who could benefit from PrEP. Outcomes for referred peers—PrEP initiation (primary), PrEP continuation (i.e., month one refills), and HIV testing (any form following referral)—were reported by index peers three months later. Implementation outcomes and costs were also assessed. Risk differences (RDs) were estimated using generalized linear mixed-effects regression models with study group fixed effects and index peer random effects. From May 3, 2023 to February 16, 2024, 316 index peers were screened and 82 enrolled/randomized (median age 22 years, IQR 20−23): 40 to the enhanced group and 42 to the standard. No index peers were lost to follow-up. Index peers reported outcomes for 241 referred peers (median age 22 years, IQR 21−24): 137 in the enhanced group and 104 in the standard. At follow-up, there were no significant differences in PrEP initiation between the enhanced group (30%, 41/137) and the standard (41%, 41/104; RD −6%, 95% CI [−26%, 11%], p = 0.51). Enhanced peer referral was not associated with PrEP continuation (RD 1%, 95% CI [−10%, 13%], p = 0.82) but was associated with increased recent HIV testing (RD 39%, 95% CI [24%, 54%], p < 0.001). Three referred peers, all in the enhanced group, tested HIV–positive; two social harms (verbal abuse among index peers, one in each group) were reported. Index and referred peers in both study groups found enhanced peer referral acceptable and feasible, but it cost almost eight times more per peer referred to PrEP than standard referral ($23 versus $3 USD). Relying on index peers to report outcomes for referred peers was a study limitation. Conclusions: Enhanced peer PrEP referral with training and HIVST delivery did not increase PrEP initiation among Kenyan AGYW but was associated with increased HIV testing, suggesting opportunities to combine peer-delivered HIVST with additional implementation strategies to improve AGYW’s PrEP engagement.


  • Open Access

    Supplementary Table S1 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Table S1: Presence or Absence of the nusG Gene, detected by three different Primer and Probe Sets in the Genomes of Bacteria in the Genus Fusobacterium Available from NCBI.

  • Open Access

    Supplementary Figure S5 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Figure S5: Serial dilution of nusG gene copies added to human genomic DNA extracted from FFPE human tissue using qPCR.

  • Open Access

    Supplementary Figure S3 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Figure S3: Serial dilution of nusG gene copies added to human genomic DNA extracted from FFPE human tissue to determine the limit of detection (LOD) and limit of quantitation (LOQ) of nusG using ddPCR.

  • Open Access

    Supplementary Figure S4 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Figure S4: Detection of a serial dilution of nusG template using qPCR systems for the assessment of linearity.

  • Open Access

    Supplementary Figure S2 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Figure S2: ddPCR data viewed as 1-D plot, with fluorescence amplitude plots of FAM-labeled probe for Fusobacterium nucleatumnusG assay from 3 different studies

  • Open Access

    Supplementary Figure S1 from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Supplementary Figure S1: Physical agitation increased genomic DNA yield.

  • Open Access

    Data from Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Background:Fusobacterium nucleatum (Fn) has been associated with the risk of colorectal cancer, poor colorectal cancer survival, and tumor attributes. Accurate and sensitive detection of Fn in tumor tissue is critical for evaluating their role in colorectal cancer.Methods:We developed a droplet digital PCR (ddPCR) assay for detecting Fn using the transcription termination/antitermination gene (nusG) normalized for host tissue (solute carrier organic anion transporter family member 2A1). We assayed Fn(nusG) in matched tumor and normal tissues for 613 participants in the Seattle site of the Colon Cancer Family Registry. We used logistic regression to determine the odds of Fn enrichment in tumor tissue according to the tumor site and stage, adjusting for age, sex, and body mass index.Results:The limit of quantitation for Fn(nusG) was 4.1 copies/10 ng host tissue. Detection of Fn was quenched and poor at low levels in formalin-fixed, paraffin-embedded tissues using qPCR. There was a low agreement between qPCR and ddPCR (Cohen’s kappa = 0.46). Fn(nusG) was detected in tumor (21%) and normal (10%) tissues and was enriched in 19% of tumors. Individuals with tumors enriched in Fn were more likely to be female (59% vs. 48%, respectively; P = 0.04) with proximal colon tumors (57% vs. 43%; P = 0.026). In multivariable-adjusted analyses, proximal colon tumors were significantly associated with Fn enrichment (OR vs. rectal tumors: 1.86; 95% confidence interval, 1.11–3.24).Conclusions:We established a sensitive and specific method to detect Fn enrichment in human tissues.Impact:ddPCR enhanced detection of Fn(nusG) for studies targeting tumor-associated bacteria.

  • Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors

    by Meredith A.J. Hullar, Orsalem J. Kahsai, Courtney Hill, Lisa Levy, Rachel C. Malen, Keith R. Curtis, Hamza Ammar, Arthur Sillah, Adriana M. Reedy, Johanna W. Lampe, et al.

    Background: Fusobacterium nucleatum (Fn) has been associated with the risk of colorectal cancer, poor colorectal cancer survival, and tumor attributes. Accurate and sensitive detection of Fn in tumor tissue is critical for evaluating their role in colorectal cancer. Methods: We developed a droplet digital PCR (ddPCR) assay for detecting Fn using the transcription termination/antitermination gene (nusG) normalized for host tissue (solute carrier organic anion transporter family member 2A1). We assayed Fn(nusG) in matched tumor and normal tissues for 613 participants in the Seattle site of the Colon Cancer Family Registry. We used logistic regression to determine the odds of Fn enrichment in tumor tissue according to the tumor site and stage, adjusting for age, sex, and body mass index. Results: The limit of quantitation for Fn(nusG) was 4.1 copies/10 ng host tissue. Detection of Fn was quenched and poor at low levels in formalin-fixed, paraffin-embedded tissues using qPCR. There was a low agreement between qPCR and ddPCR (Cohen’s kappa = 0.46). Fn(nusG) was detected in tumor (21%) and normal (10%) tissues and was enriched in 19% of tumors. Individuals with tumors enriched in Fn were more likely to be female (59% vs. 48%, respectively; P = 0.04) with proximal colon tumors (57% vs. 43%; P = 0.026). In multivariable-adjusted analyses, proximal colon tumors were significantly associated with Fn enrichment (OR vs. rectal tumors: 1.86; 95% confidence interval, 1.11–3.24). Conclusions: We established a sensitive and specific method to detect Fn enrichment in human tissues. Impact: ddPCR enhanced detection of Fn(nusG) for studies targeting tumor-associated bacteria.